0
Oncolytics Biotech Inc. Banner Image

Oncolytics Biotech Inc.

  • Ticker ONC
    Exchange TSX More
  • Industry Biotechnology More
  • Sector Healthcare More
Oncolytics Biotech Inc. Logo Image
  • 11-50 Employees
  • Based in Calgary, Alberta
Oncolytics Biotech Inc. is developing pelareorep, a safe and well-tolerated intravenously delivered immuno-oncolytic virus (IOV) that targets cancer through a unique mechanism of action with two components, selective tumor lysis and activation of the innate and adaptive immune systems, creating an inflamed phenotype to treat a variety of solid tumors and hematological malignancies.
Oncolytics Biotech Inc.

Most Recent Annual Report

Oncolytics Biotech Inc.
MOST RECENT 2020 Annual Report

Older/Archived Annual Reports